One for all—human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses
暂无分享,去创建一个
C. Hastie | N. Kriplani | N. Craig | C. Tait-Burkard | A. Kratzel | S. Fletcher | Alison Daniels | Holly E M Kerr | Rute Maria Pinto | Paul Davies | Paul Digard | Volker Thiel
[1] S. Ciesek,et al. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection , 2022, bioRxiv.
[2] W. Bayer,et al. Changes in Symptoms Experienced by SARS-CoV-2-Infected Individuals – From the First Wave to the Omicron Variant , 2022, Frontiers in Virology.
[3] Y. Kamatani,et al. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication , 2022, Communications Biology.
[4] A. Baiker,et al. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models , 2022, Virology Journal.
[5] Zigui Chen,et al. Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens , 2022, Microbiology spectrum.
[6] W. Tan,et al. Direct Lysis RT-qPCR of SARS-CoV-2 in Cell Culture Supernatant Allows for Fast and Accurate Quantification , 2022, Viruses.
[7] Y. Nakata,et al. SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer , 2022, Journal of Biological Chemistry.
[8] Frances E. Muldoon,et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.
[9] H. Zayed,et al. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters , 2021, Microbiology spectrum.
[10] C. Uphoff,et al. Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies , 2021, PloS one.
[11] J. Garrido,et al. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns , 2021, Frontiers in Immunology.
[12] Haohao Dong,et al. Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity , 2021, Nucleic acids research.
[13] Yong Lin,et al. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes , 2021, Cell Discovery.
[14] P. Shi,et al. Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses , 2021, Emerging infectious diseases.
[15] P. Chaudhary,et al. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 , 2021, Cells.
[16] M. Kane,et al. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor , 2021, Cell & bioscience.
[17] G. Zimmer,et al. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets , 2021, bioRxiv.
[18] D. Qu,et al. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry , 2021, Nature Communications.
[19] D. Robertson,et al. A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research , 2021, PLoS biology.
[20] R. Baric,et al. Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques , 2021, Journal of Virology.
[21] R. Gautier,et al. A comprehensive library of fluorescent constructs of SARS‐CoV‐2 proteins and their initial characterisation in different cell types , 2020, Biology of the cell.
[22] D. Lavillette,et al. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles , 2020, Journal of Biological Chemistry.
[23] Silva Kasela,et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells , 2020, Cell.
[24] Peter C. DeWeirdt,et al. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection , 2020, Cell.
[25] Francisco J. Sánchez-Rivera,et al. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks , 2020, bioRxiv.
[26] M. Fukushi,et al. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant , 2020, Cell Reports.
[27] L. Guddat,et al. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase , 2020, Cell.
[28] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[29] O. Tsang,et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study , 2020, The Lancet Microbe.
[30] Natacha S. Ogando,et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology , 2020, bioRxiv.
[31] Francisco J. Sánchez-Rivera,et al. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks , 2020, Cell.
[32] Benjamin J Cowling,et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[33] Rolf Hilgenfeld,et al. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein , 2017, Antiviral Research.
[34] F. Taguchi,et al. The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles. , 2016, The Journal of general virology.
[35] P. Mayer,et al. Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes , 2016, Scientific Reports.
[36] Mones Abu-Asab,et al. SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome , 2014, The Journal of Immunology.
[37] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[38] R. Geffers,et al. Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential , 2013, mBio.
[39] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[40] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[41] D. Speiser,et al. Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity , 2010, mBio.
[42] Byoung-Hee Lee,et al. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43 , 2010, Journal of veterinary science.
[43] K. Essani,et al. Differential Susceptibility of Human Cancer Cell Lines to Wild-Type Tanapoxvirus Infection , 2010, The open virology journal.
[44] John R. Yates,et al. Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signaling , 2009, Journal of Virology.
[45] M. Lenardo,et al. Molecular Determinants for Subcellular Localization of the Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame 3b Protein , 2009, Journal of Virology.
[46] J. Li,et al. The Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains a Novel Endoplasmic Reticulum Retrieval Signal That Binds COPI and Promotes Interaction with Membrane Protein , 2006, Journal of Virology.
[47] Andrew Pekosz,et al. The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV Particles , 2006, Journal of Virology.
[48] Wei Lu,et al. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release , 2006, Proceedings of the National Academy of Sciences.
[49] J. Cheng,et al. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[50] L. Enjuanes,et al. Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. , 2005, The Journal of general virology.
[51] Lucy A. Perrone,et al. Apical Entry and Release of Severe Acute Respiratory Syndrome-Associated Coronavirus in Polarized Calu-3 Lung Epithelial Cells , 2005, Journal of Virology.
[52] Shengqi Wang,et al. Subcellular localization and membrane association of SARS-CoV 3a protein , 2005, Virus Research.
[53] A. Osterhaus,et al. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. , 2004, Virus research.
[54] Y. Guan,et al. Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.
[55] P. Collins,et al. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. , 2000, Virology.
[56] J. Melnick,et al. Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) , 1968, Journal of virology.
[57] M. Mayo,et al. Virus Taxonomy , 1991, Archives of Virology Supplement 10.